Generex Biotech Stock Price (OTCMKTS:GNBT)

Add to My Stocks
$1.88 $0.09 (4.57%) GNBT stock closing price Sep 19, 2018 (Closing)
Prev Close* : $1.97
Market Cap:
$2.1M
Day Low: $1.85
52 Week Low: $1.76
Open: $1.91
Volume: -
Day High: $1.91
52 Week High: $4.59
Dividend:
0.00

Latest Stock Market News

Latest Articles

Generex Biotech News - From Partners

GNBT Stockcharts

View GNBT PE ratio, PS ratio stocks charts and compare with peers.
GNBT Chart
Note: Compare Generex Biotech stock price history with the index and industry peers.

Generex Biotech Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
-999.0000
PB ratio (
price to book ratio
)
-999.0000

Generex Biotech Returns

ROE
(return on equity)
-

Generex Biotech Financial Ratios

Asset Turnover
0
Receivables Turnover
-
Debt to Equity
-
Dividend Yield
-999.0000

GNBT Industry Peers

Company Price Change (%)
Cotinga Pharma (COTQF)0.140 (0%)
Aoxing Pharma (AOXG)0.030 (0%)
Novo Nordisk (NVO)470.43 (0.91%)
Acerus Pharma (TRLPF)0.210 (0%)
Mannkind (MNKD)1.720.01 (0.58%)
Astrazeneca (AZN)37.30.19 (0.51%)
Glaxosmithkline (GSK)39.550.08 (0.2%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
MOLECULAR TEMPL (MTEM)6.252.15 (52.44%)
Neptune Tech. & Bio. (NEPT)4.710.44 (10.3%)
Infinity Pharma (INFI)2.310.18 (8.45%)
Pacira Pharma (PCRX)51.353.5 (7.31%)
Aratana Therapeutics (PETX)5.840.39 (7.16%)
Achaogen (AKAO)4.560.28 (6.54%)
La Jolla Pharma (LJPC)22.071.12 (5.35%)
Top gainers from Medical-Drugs industry
* As of Sep 20, 2018
CompanyPriceChange (%)
PTC Therapeutics (PTCT)45.371.82 (3.86%)
USANA Health Sciences (USNA)119.354.75 (3.83%)
Esperion Therapeutics (ESPR)45.571.69 (3.58%)
ArQule (ARQL)4.850.17 (3.39%)
Zogenix (ZGNX)47.051.6 (3.29%)
Nektar Therapeutics (NKTR)56.691.64 (2.81%)
Durect (DRRX)1.10.03 (2.65%)
Top losers from Medical-Drugs industry
* As of Sep 20, 2018

Generex Biotech Financial Statements

income statement20172016201520142013
Net Sales or Revenues-----
Net Income-70.01M-3.22M-2.19M--8.55M
Total Operating Expense1.17M1.43M3.87M4.39M6.12M
View Generex Biotech income statement
balance sheet20172016201520142013
Total Assets10.09M-2.23M5.52M4.85M
Total Liabilities89.97M11.24M10.52M11.61M14.99M
Shareholders Equity-79.87M-11.21M-8.29M-6.09M-10.14M
View Generex Biotech balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-1.1M-0.19M-0.59M-
Net Cash from (used by) Operating Activities-1.17M-0.77M-2.88M-3.57M-3.66M
Increase (Decrease) in Prop Plant And Equipment----1.76M
View Generex Biotech cash flow statement

Generex Biotech Stock Message Board

As of last trading day, Generex Biotech stock price was $1.88. Generex Biotech market capitalization is $2.1M and it represents the total market value of GNBT stock. Generex Biotech valuation can be guaged using various valuation metrics like the price to earnings ratio.

For recognizing and analyzing the real performance of Generex Biotech stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. 2,451 GNBT shares were traded yesterday, and Generex Biotech stock chart shows that the GNBT stock quote hit a day high of $1.91 and day low of $1.85. Generex Biotech paid 0.00 stock dividends to its shareholders during last quarter. To check the historical stock price movement, all time high, and all time low of GNBT, view Generex Biotech stock price history.